Showing 421-430 of 936 results for "".
Noninflammatory Myopathies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/noninflammatory-myopathies/31557/As genetic diagnosis increases, noninflammatory myopathies are being seen more in clinical practice.Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processHypermobility Spectrum Disorders and Migraine: Screening Matters
https://practicalneurology.com/diseases-diagnoses/headache-pain/hypermobility-spectrum-disorders-and-migraine-screening-matters/36118/This article reviews the association between hypermobility spectrum disorders and migraine, highlighting the importance of screening for these disorders in people with migraine to improve diagnosis, management, and outcomes.Care of Individuals with Neurofibromatosis Type 1 Amid an Evolving Paradigm of Therapeutic Development
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/care-of-individuals-with-neurofibromatosis-type-1-amid-an-evolving-paradigm-of-therapeutic-development/35583/Treatment for individuals with neurofibromatosis type 1, a complex disease with variabilities in presentation and disease course, requires a multidisciplinary approach with emphasis on surveillance along with ongoing discussion of therapeutic interventions.Rapidly Progressive Dementia and Plateau Waves: A Rare Presentation of Leptomeningeal Disease
https://practicalneurology.com/programs/practical-neurology/rapidly-progressive-dementia-and-plateau-waves-a-rare-presentation-of-leptomeningeal-disease/33145/The authors present a rare clinical marker in a patient with rapidly progressive dementia which can aid appropriate diagnostic evaluation.AntiCD20+ Agents
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/anticd20-agents/31630/AntiCD20+ agents are among the highest efficacy treatments for multiple sclerosis.Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Case Report: Cerebral Aneurysm Rerupture
https://practicalneurology.com/diseases-diagnoses/stroke/case-report-cerebral-aneurysm-rerupture/31817/Antifibrinolytic therapy may induce cerebral aneurysmal thrombosis that can obscure unstable aneurysms, delaying diagnosis and treatment.Genomics to Gene Therapy in Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/genomics-to-gene-therapy-in-neurology/31565/Recent advances in neurogenomics are changing how we practice neurology.Intranasal Acute Migraine Treatments
https://practicalneurology.com/diseases-diagnoses/headache-pain/intranasal-acute-migraine-treatments/32128/Intranasal options for acute migraine treatment provide rapid-onset relief, especially for people with nausea, vomiting, or gastroparesis; needle phobia; or intolerance to injectable formulations.